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Background
Opioids for Surgical Pain
Opioids play an important 
role in management of 
postsurgical pain
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Opioids for Surgical Pain
Opioids play an important 
role in management of 
postsurgical pain
Clinical challenge of striking 
the balance between safe 
and adequate pain 
management 
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Unused Opioids After Surgery
Patients routinely receive more opioids than medically 
necessary for adequate postsurgical pain management. 
6JAMA Surg. 2017;152(11):1066-1071. doi:10.1001/jamasurg.2017.0831
Prevalence of Unused Opioids Prescribed After Surgery
Day Supply Prescribing Limits
7https://www.athenahealth.com/insight/infographic-opioid-regulations-state-by-state
Day Supply Prescribing Limits
8https://www.athenahealth.com/insight/infographic-opioid-regulations-state-by-state
• Policies vary state by state




Among a broad cohort of opioid-naïve 
surgical patients in the US, examine 
trends in:  
1) The proportion of patients filling opioid 
prescriptions for postsurgical pain
2) The initial volume of opioids prescribed 
Methods
Study Schematic
Data Source: MarketScan Commercial Claims and 
Medicare Supplemental (2006 – 2015)
11
≥ 180-day continuous enrollment
Baseline comorbidities:
- No surgery
- No addiction / poisoning
- No naloxone Rx
- No opioid Rx (-7 days)
Outpatient 
Surgery Date Initial Opioid Rx
-7 days +7 days
Annual Trends
Proportion of patients receiving a perioperative opioid 
Rx
Proportion of patients whose initial opioid Rx 
exceeded varying cutpoints
▪ Days Supply: 7 days
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Annual Trends
Proportion of patients receiving a perioperative opioid 
Rx
Proportion of patients whose initial opioid Rx 
exceeded varying cutpoints
▪ Days Supply: 7 days
▪ Dosage: 400 MME





Total Surgeries N = 5,148,485
Female 54.5%






Perioperative Opioid Rx 55.5%
Initial DS 5 (3,6)
Initial Qty 30 (28,40)
Initial MME 240 (180, 360)
Surgical Population
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Total Surgeries N = 5,148,485
Female 54.5%






Perioperative Opioid Rx 55.5%
Initial DS 5 (3,6)
Initial Qty 30 (28,40)
Initial MME 240 (180, 360)
Ocular 
(10.3%)
4 Most Common Procedures
Surgical Population
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4 Most Common Procedures
Surgical Population
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Total Surgeries N = 5,148,485
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4 Most Common Procedures
Surgical Population
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Total Surgeries N = 5,148,485
Female 54.5%






Perioperative Opioid Rx 55.5%
Initial DS 5 (3,6)
Initial Qty 30 (28,40)














1) Examine trends in the proportion of 
patients filling opioid prescriptions for 
postsurgical pain
Perioperative Opioid Rx by Year
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Perioperative Opioid Rx by Year
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Perioperative Opioid Rx by Year
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Perioperative Opioid Rx by Year
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Perioperative Opioid Rx by Year
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Perioperative Opioid Rx by Year
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Perioperative Opioid Rx by Year
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Perioperative Opioid Rx by Year
30
Perioperative Opioid Rx by Year
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2) Examine trends in the proportion of 
patients receiving prescriptions above 
varying cutpoints
Opioid Rx Exceeding Cutpoints by Year
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Opioid Rx Exceeding Cutpoints by Year
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Opioid Rx Exceeding Cutpoints by Year
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Overall Trends in Prescribing
The Net Effect?
Opioids Prescribed / Procedure
39
Opioids Prescribed / Procedure
40
Opioids Prescribed / Procedure
41
Pills per Day / Procedure
42








▪ The proportion of surgical patients receiving a 
perioperative opioid began to decrease after 2013
▪ Among those receiving opioids, the probability of 
receiving a prescription above recommended 
thresholds continued to increase
▪ On average, the quantity of pills and dosage 





▪ Large claims data, 2006-2015
▪ Broad surgical population
▪ Detailed information on days supplied, quantity and 
dosage dispensed
Limitations
▪ Commercially insured patients
▪ Limited information on pain severity
▪ Limited ability to identify prescribing physician 
46
Public Health Impact
▪ Characterizing opioid use is complicated
▪ Different dimensions of opioid prescribing can yield 
different perspectives on prescribing trends 
• Quantity and dosing are specified on a prescription
























Total Surgeries N = 5,148,485
Female 54.5%






Perioperative Opioid Rx 55.5%
Initial DS 5 (3,6)
Initial Qty 30 (28,40)
























Surgical Procedures by Year
51
Opioids Prescribed by Year
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Opioids Prescribed by Year
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Surgical Population
% of All Surgeries % of All Surgeries
Total Surgeries (N) 5,148,485
Female 54.5% 54.5%
Age – Median (IQR) 47 (27, 60)







Knee arthroscopy surgery 511,067 9.9%
Tonsillectomy/adenoidectomy 363,390 7.1%
Laparoscopic cholecystectomy 279,812 5.4%
Myringotomy 252,076 4.9%
Inguinal and femoral hernia repair 220,804 4.3%
Other hernia repair 167,504 3.3%
Lumpectomy 152,829 3.0%
Bunionectomy 136,017 2.6%
Plastic procedures on nose 129,735 2.5%











Median (IQR) Median (IQR) Median (IQR)
Overall N=2,857,115 5 (3,6) 30 (28,40) 240 (180, 360)
Gender
Female 55.34% 5 (3,6) 30 (25,40) 225 (180, 300)
Male 44.65% 5 (3,6) 30 (30,40) 240 (180, 360)
Age Category
Under 25 23.3% 5 (3,6) 30 (28,42) 240 (150,360)
25-44 22.0% 5 (3,5) 30 (25,40) 225 (180,337.5)
45-64 39.2% 5 (3,6) 30 (30,40) 240 (180,360)
65-84 14.0% 5 (3,6) 30 (24,40) 225 (150,300)
85+ 1.6% 5 (3,5) 30 (20,30) 180 (120,240)
Variation in Postsurgical Prescribing
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Opioid Prescription Size and ConsumptionMedian opioid prescription size and patient-reported consumption for all 12 procedures in 
tablets of hydrocodone/acetaminophen, 5/325 mg. Quantity of opioid prescribed was significantly greater than patient consumption
for all procedures.
Figure Legend: 
